283 related articles for article (PubMed ID: 11772254)
1. Therapeutic potential of COX-2 inhibitors in arthritis.
Jackson CG
Expert Opin Investig Drugs; 2001 Jul; 10(7):1317-25. PubMed ID: 11772254
[TBL] [Abstract][Full Text] [Related]
2. Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks.
Bertolini A; Ottani A; Sandrini M
Curr Med Chem; 2002 May; 9(10):1033-43. PubMed ID: 12733982
[TBL] [Abstract][Full Text] [Related]
3. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
4. COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs.
Everts B; Währborg P; Hedner T
Clin Rheumatol; 2000; 19(5):331-43. PubMed ID: 11055820
[TBL] [Abstract][Full Text] [Related]
5. Are the biologic and clinical effects of the COX-2-specific inhibitors an advance compared with the effects of traditional NSAIDs?
Simon LS
Curr Opin Rheumatol; 2000 May; 12(3):163-70. PubMed ID: 10803743
[TBL] [Abstract][Full Text] [Related]
6. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
7. COX-2 specific inhibitors offer improved advantages over traditional NSAIDs.
Urban MK
Orthopedics; 2000 Jul; 23(7 Suppl):S761-4. PubMed ID: 10914695
[TBL] [Abstract][Full Text] [Related]
8. The unmet anti-inflammatory needs in orthopedics.
Trippel SB
Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):3-7. PubMed ID: 10193996
[TBL] [Abstract][Full Text] [Related]
9. Intelligent use of NSAIDs--where do we stand?
Berger RG
Expert Opin Pharmacother; 2001 Jan; 2(1):19-30. PubMed ID: 11336565
[TBL] [Abstract][Full Text] [Related]
10. COX-2 inhibitors. What is their place?
McGettigan P
Aust Fam Physician; 2000 Sep; 29(9):847-52. PubMed ID: 11008387
[TBL] [Abstract][Full Text] [Related]
11. Is there a place for non-selective NSAIDs in the treatment of arthritis?
Crofford LJ
Joint Bone Spine; 2002 Jan; 69(1):4-7. PubMed ID: 11858355
[No Abstract] [Full Text] [Related]
12. Selective cyclooxygenase-2 inhibitors.
Golden BD; Abramson SB
Rheum Dis Clin North Am; 1999 May; 25(2):359-78. PubMed ID: 10356423
[TBL] [Abstract][Full Text] [Related]
13. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
Tishler M; Langevetiz P; Nesher G
Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
[No Abstract] [Full Text] [Related]
14. Efficacy of cyclooxygenase-2-specific inhibitors.
Cannon GW; Breedveld FC
Am J Med; 2001 Feb; 110 Suppl 3A():6S-12S. PubMed ID: 11173044
[TBL] [Abstract][Full Text] [Related]
15. Developing an economic rationale for the use of selective COX-2 inhibitors for patients at risk for NSAID gastropathy.
Fendrick AM
Cleve Clin J Med; 2002; 69 Suppl 1():SI59-64. PubMed ID: 12086296
[TBL] [Abstract][Full Text] [Related]
16. COX-2--selective NSAIDs.
Hutchison R
Am J Nurs; 2004 Mar; 104(3):52-5; quiz 55-6. PubMed ID: 15108571
[No Abstract] [Full Text] [Related]
17. Clinical pharmacology of selective COX-2 inhibitors.
Capone ML; Tacconelli S; Sciulli MG; Patrignani P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility.
Cronstein BN
Cleve Clin J Med; 2002; 69 Suppl 1():SI13-9. PubMed ID: 12086289
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2: a therapeutic target.
Turini ME; DuBois RN
Annu Rev Med; 2002; 53():35-57. PubMed ID: 11818462
[TBL] [Abstract][Full Text] [Related]
20. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications.
Pascucci RA
J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
